Cargando…
Neuroprotective Mechanisms of Glucagon-Like Peptide-1-Based Therapies in Ischemic Stroke: An Update Based on Preclinical Research
The public and social health burdens of ischemic stroke have been increasing worldwide. Hyperglycemia leads to a greater risk of stroke. This increased risk is commonly seen among patients with diabetes and is in connection with worsened clinical conditions and higher mortality in patients with acut...
Autores principales: | Yang, Xiaoyan, Qiang, Qiang, Li, Nan, Feng, Peng, Wei, Wenshi, Hölscher, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964641/ https://www.ncbi.nlm.nih.gov/pubmed/35370875 http://dx.doi.org/10.3389/fneur.2022.844697 |
Ejemplares similares
-
The neuroprotective effects of glucagon-like peptide 1 in Alzheimer’s and Parkinson’s disease: An in-depth review
por: Reich, Niklas, et al.
Publicado: (2022) -
Neuroprotective Effects of Deproteinized Calf Serum in Ischemic Stroke
por: Li, Weiwei, et al.
Publicado: (2021) -
Ischemic stroke: From pathological mechanisms to neuroprotective strategies
por: Jiang, Yang, et al.
Publicado: (2022) -
Systematic Review - Combining Neuroprotection With Reperfusion in Acute Ischemic Stroke
por: Vos, E. M., et al.
Publicado: (2022) -
A Network-Based Method for Mechanistic Investigation and Neuroprotective Effect on Post-treatment of Senkyunolid-H Against Cerebral Ischemic Stroke in Mouse
por: Zhang, Jie, et al.
Publicado: (2019)